Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral (Z)-Endoxifen for Gonadotropin-Independent Precocious Puberty in Girls With McCune-Albright Syndrome
NCT07869732Phase 2Not yet recruiting
- Sponsor
- Atossa Therapeutics
- Start
- Mar 2027
- Primary completion
- Jun 2028
- Countries
- 1
01
Overview
A Phase 2 trial of z-endoxifen in precocious puberty, sponsored by Atossa Therapeutics. Planned start Mar 2027; status: not yet recruiting.
02
Drugs
z-endoxifen
03
Conditions
precocious puberty
Beyond the preview
Go deeper on NCT07869732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07869732.